Skip to content

Homoeopathic treatment of nasal congestion, sneezing, rhinorrhea and nasal itching in adults

Efficacy of individualized homoeopathic medicines in the treatment of perennial allergic rhinitis in adults: A double-blind, randomized, placebo-controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/08/115401
Enrollment
130
Registered
2026-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines plus concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will consi
dosage and repetition depend upon the individual requirement of the cases. Concomitant care for perennial allergic rhinitis includes steam inhalation, allergen avoidance, saline nasal irrigation, app

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient suffering from perennial AR of mild to moderate intensity [ICD 11 CA08.0Z]. 2. Age 18 to 65 years and of either sex. 3. History of recurrent attack of symptoms of perennial AR since childhood. 4. Elevated absolute eosinophil count and elevated total Serum IgE level.

Exclusion criteria

Exclusion criteria: 1. Nasal abnormalities causing obstruction e.g. nasal polyps, deviated septum. 2. Away from usual environment for more than 1 week during trial. 3. Patient not providing written informed consent voluntarily. 4. Seasonal allergic rhinitis 5. Respiratory infections 6. Patients with risk of developing bronchial asthma 7. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life. 8. Pregnant and puerperal women, and lactating mothers 9. Substance abuse and/or dependence 10. Self-reported immune-compromised state 11. Oral or parenteral steroids in past 6 months 12. Not having any previous history of allergic attack of symptoms of AR. 13. Undergoing Homoeopathic treatment for any chronic disease within last 6 months. 14. Vulnerable population- unconscious, non-ambulatory, too sick for consultation, differently abled, terminally and critically ill patient, mentally incompatible patients.

Design outcomes

Primary

MeasureTime frame
Total Nasal Symptoms Score [TNSS]Timepoint: At baseline and every month upto 3 months

Secondary

MeasureTime frame
Mini- Rhino-Conjunctivitis Quality of Life Questionnaire [Mini-RQLQ]Timepoint: Baseline and every month upto 3 months;Measure Yourself Medical Outcome Profile version 2 [MYMOP-2] questionnaireTimepoint: Baseline and every month upto 3 months;Total Serum IgE level with absolute eosinophil countTimepoint: Baseline and third month

Countries

India

Contacts

Public ContactArpita Basu

D N De Homoeopathic Medical College and Hospital

drarpitasen@gmail.com9830273374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026